Axios Newsletter

Axios: StemoniX Lands $14.4M to Continue Development of ‘Micro-Organs’

March 1, 2019 – StemoniX Inc, a Minnesota-based biotech company, has secured $14.4 million in Series B funding led by Brightstone Venture Capital, with Crescent Ridge Partners, SEED San Diego, Alumni Ventures Group, Keshif Ventures and Mayo Clinic also participating.